| Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19 JN Kochenderfer, WH Wilson, JE Janik, ME Dudley, M Stetler-Stevenson, ... Blood, The Journal of the American Society of Hematology 116 (20), 4099-4102, 2010 | 1600 | 2010 |
| Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma K Dunleavy, S Pittaluga, MS Czuczman, SS Dave, G Wright, N Grant, ... Blood, The Journal of the American Society of Hematology 113 (24), 6069-6076, 2009 | 626 | 2009 |
| Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting K Tsukasaki, O Hermine, A Bazarbachi, L Ratner, JC Ramos, ... Journal of Clinical Oncology 27 (3), 453, 2009 | 592 | 2009 |
| Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication RML Buller, JE Janik, ED Sebring, JA Rose Journal of virology 40 (1), 241-247, 1981 | 503 | 1981 |
| Progress on new vaccine strategies for the immunotherapy and prevention of cancer JA Berzofsky, M Terabe, SK Oh, IM Belyakov, JD Ahlers, JE Janik, ... The Journal of clinical investigation 113 (11), 1515-1525, 2004 | 442 | 2004 |
| Brentuximab vedotin (SGN-35) J Katz, JE Janik, A Younes Clinical cancer research 17 (20), 6428-6436, 2011 | 431 | 2011 |
| High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the … U Hegde, A Filie, RF Little, JE Janik, N Grant, SM Steinberg, K Dunleavy, ... Blood 105 (2), 496-502, 2005 | 416 | 2005 |
| Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy WH Wilson, ML Grossbard, S Pittaluga, D Cole, D Pearson, N Drbohlav, ... Blood, The Journal of the American Society of Hematology 99 (8), 2685-2693, 2002 | 415 | 2002 |
| Phase II study of dose-adjusted EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers WH Wilson, K Dunleavy, S Pittaluga, U Hegde, N Grant, SM Steinberg, ... Journal of clinical oncology: official journal of the American Society of …, 2008 | 400 | 2008 |
| Mycosis fungoides and Sézary syndrome ST Hwang, JE Janik, ES Jaffe, WH Wilson The Lancet 371 (9616), 945-957, 2008 | 345 | 2008 |
| Interleukin 1α increases serum leptin concentrations in humans JE Janik, BD Curti, RV Considine, HC Rager, GC Powers, WG Alvord, ... The Journal of Clinical Endocrinology & Metabolism 82 (9), 3084-3086, 1997 | 324 | 1997 |
| Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma SJ Schuster, SS Neelapu, BL Gause, JE Janik, FM Muggia, ... Journal of clinical oncology 29 (20), 2787, 2011 | 278 | 2011 |
| PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance V Verma, RK Shrimali, S Ahmad, W Dai, H Wang, S Lu, R Nandre, P Gaur, ... Nature immunology 20 (9), 1231-1243, 2019 | 255 | 2019 |
| Progress on new vaccine strategies against chronic viral infections JA Berzofsky, JD Ahlers, J Janik, J Morris, SK Oh, M Terabe, IM Belyakov The Journal of clinical investigation 114 (4), 450-462, 2004 | 223 | 2004 |
| Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin RJ Kelly, A Lopez-Chavez, D Citrin, JE Janik, JC Morris Molecular cancer 10, 1-11, 2011 | 220 | 2011 |
| Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment BD Curti, WJ Urba, W Gregory Alvord, JE Janik, JW Smith, K Madara, ... Cancer research 53 (10), 2204-2207, 1993 | 213 | 1993 |
| The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies. JW Smith 2nd, WJ Urba, BD Curti, LJ Elwood, RG Steis, JE Janik, ... Journal of clinical oncology 10 (7), 1141-1152, 1992 | 196 | 1992 |
| A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy D O'Mahony, JC Morris, C Quinn, W Gao, WH Wilson, B Gause, ... Clinical Cancer Research 13 (3), 958-964, 2007 | 177 | 2007 |
| The effects of treatment with interleukin-1α on platelet recovery after high-dose carboplatin JW Smith, DL Longo, WG Alvord, JE Janik, WH Sharfman, BL Gause, ... New England Journal of Medicine 328 (11), 756-761, 1993 | 162 | 1993 |
| CNS involvement in primary mediastinal large B-cell lymphoma PC Bishop, WH Wilson, D Pearson, J Janik, ES Jaffe, PC Elwood Journal of Clinical Oncology 17 (8), 2479-2479, 1999 | 154 | 1999 |
